Protective effects of BML-111 against acetaminophen-induced acute liver injury in mice
- 14 September 2013
- journal article
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 70 (1) , 141-149
Abstract
The present study was undertaken to investigate the effect of the new formyl peptide receptor 2/lipoxin A4 receptor agonist BML-111 on acetaminophen (APAP)-induced liver injury in mice and explore its possible mechanism(s). Male Swiss albino mice were intraperitoneally injected with BML-111 (1 mg/kg) twice daily for five consecutive days prior to a single intraperitoneal injection of APAP (500 mg/kg). Results have shown that APAP injection caused liver damage as indicated by significant increase in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP). Liver histopathological examination revealed marked necrosis and inflammation. Additionally, APAP decreased activities of hepatic glutathione (GSH) and superoxide dismutase (SOD) with significant increase in the hepatic malondialdehyde (MDA) content. Furthermore, APAP increased serum nitrite/nitrate (NO2 −/NO3 − ) level and hepatic tumor necrosis factor alpha (TNF-α). Pretreatment with BML-111 significantly reversed all APAP-induced pathological changes. BML-111 prevented the increase of AST, ALT, and ALP. Also, BML-111 markedly attenuated APAP-induced necrosis and inflammation. It decreased MDA with increase in SOD and GSH. Importantly, BML-111 decreased NO2 −/NO3 − level and TNF-α. These findings suggest that BML-111 has hepatoprotective effects against APAP-induced liver injury in mice. Its protective effect may be attributed to its ability to counteract the inflammatory ROS generation and regulate cytokine effects.Keywords
This publication has 46 references indexed in Scilit:
- Treatment of Lipoxin A4 and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanismsReproductive Toxicology, 2012
- Novel Lipid Mediators Promote Resolution of Acute InflammationCirculation Research, 2010
- Lipoxin A4 attenuates zymosan‐induced arthritis by modulating endothelin‐1 and its effectsBritish Journal of Pharmacology, 2010
- Potential role of caveolin-1 in acetaminophen-induced hepatotoxicityToxicology and Applied Pharmacology, 2010
- Lipoxins: resolutionary roadBritish Journal of Pharmacology, 2009
- Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of ForcesChemical Research in Toxicology, 2009
- Anti-Inflammatory and Proresolving Lipid MediatorsAnnual Review of Pathology: Mechanisms of Disease, 2008
- Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expressionNature Immunology, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal diseaseKidney International, 2004